Print

Bristol-Myers Squibb Company (BMY) to Keep a Seattle Presence; to Preserve About 275 ZymoGenetics, Inc. (ZGEN) Jobs  
1/26/2011 6:48:15 AM

Seattle Times -- Bristol-Myers Squibb, which bought Seattle drugmaker ZymoGenetics last year, plans to keep a long-term presence in Seattle's South Lake Union district, a spokeswoman said late Tuesday.
//-->